1011003667 (0301-66) IUCRO-0042; Blood Drawing for Study of Peripheral Blood T-Lymphocytes and Other Parameters in patients with Metastatic Melanoma and Renal Cell Cancer with Spontaneous Regression



Study Overview

The purpose of this trial is to collect peripheral blood from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression in order to study immune response.


Study Description

The purpose of this trial is to collect peripheral blood from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression in order to study immune response.

Additional Information:

Participants will not be paid for their participation.



Research Study Identifier: TX1000
ClinicalTrials.gov Identifier: NCT1011003667 (0301-66)


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.